Agilent Technologies (NYSE: A) is one of 82 publicly-traded companies in the “Advanced Medical Equipment & Technology” industry, but how does it compare to its rivals? We will compare Agilent Technologies to similar companies based on the strength of its dividends, earnings, analyst recommendations, institutional ownership, valuation, risk and profitability.
This table compares Agilent Technologies and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Agilent Technologies Competitors||-330.26%||-33.54%||-12.51%|
Agilent Technologies pays an annual dividend of $0.53 per share and has a dividend yield of 0.8%. Agilent Technologies pays out 27.3% of its earnings in the form of a dividend. As a group, “Advanced Medical Equipment & Technology” companies pay a dividend yield of 0.9% and pay out 26.3% of their earnings in the form of a dividend. Agilent Technologies lags its rivals as a dividend stock, given its lower dividend yield and higher payout ratio.
Earnings & Valuation
This table compares Agilent Technologies and its rivals top-line revenue, earnings per share and valuation.
|Gross Revenue||EBITDA||Price/Earnings Ratio|
|Agilent Technologies||$4.39 billion||$1.02 billion||34.00|
|Agilent Technologies Competitors||$2.02 billion||$430.37 million||-56.73|
Agilent Technologies has higher revenue and earnings than its rivals. Agilent Technologies is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.
Volatility and Risk
Agilent Technologies has a beta of 1.3, indicating that its stock price is 30% more volatile than the S&P 500. Comparatively, Agilent Technologies’ rivals have a beta of 0.89, indicating that their average stock price is 11% less volatile than the S&P 500.
Institutional & Insider Ownership
53.1% of shares of all “Advanced Medical Equipment & Technology” companies are owned by institutional investors. 16.8% of shares of all “Advanced Medical Equipment & Technology” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
This is a summary of recent recommendations and price targets for Agilent Technologies and its rivals, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Agilent Technologies Competitors||416||2180||3387||122||2.53|
Agilent Technologies currently has a consensus target price of $65.14, indicating a potential downside of 1.24%. As a group, “Advanced Medical Equipment & Technology” companies have a potential downside of 21.22%. Given Agilent Technologies’ stronger consensus rating and higher possible upside, research analysts clearly believe Agilent Technologies is more favorable than its rivals.
Agilent Technologies beats its rivals on 10 of the 15 factors compared.
Agilent Technologies Company Profile
Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business. Its life sciences and applied markets business segment offers instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. Its diagnostics and genomics business segment includes the reagent partnership, pathology, companion diagnostics, genomics and the nucleic acid solutions businesses. Its Agilent CrossLab business segment spans the entire lab with its consumables and services portfolio.
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.